Literature DB >> 34017126

Author Correction: Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection.

Jianmin Zuo1, Alexander C Dowell1, Hayden Pearce1, Kriti Verma1, Heather M Long1, Jusnara Begum1, Felicity Aiano2, Zahin Amin-Chowdhury2, Katja Hoschler2, Tim Brooks3, Stephen Taylor3, Jacqueline Hewson3, Bassam Hallis3, Lorrain Stapley3, Ray Borrow4, Ezra Linley4, Shazaad Ahmad5, Ben Parker6,7, Alex Horsley6,8, Gayatri Amirthalingam2, Kevin Brown2, Mary E Ramsay2, Shamez Ladhani9,10, Paul Moss11.   

Abstract

Entities:  

Year:  2021        PMID： 34017126     DOI： 10.1038/s41590-021-00957-7

Source DB:  PubMed          Journal:  Nat Immunol        ISSN： 1529-2908            Impact factor:   25.606


× No keyword cloud information.
  3 in total

1.  Post-COVID-19 Fatigue and SARS-CoV-2 Specific Humoral and T-Cell Responses in Male and Female Outpatients.

Authors:  Christa Meisinger; Yvonne Goßlau; Tobias D Warm; Vincenza Leone; Alexander Hyhlik-Dürr; Jakob Linseisen; Inge Kirchberger
Journal:  Front Immunol       Date:  2022-05-26       Impact factor: 8.786

2.  Comprehensive Humoral and Cellular Immune Responses to SARS-CoV-2 Variants in Diverse Chinese Population.

Authors:  Jiwei Li; Jing Wu; Qiuyue Long; Yan'an Wu; Xiaoyi Hu; Yukun He; Mingzheng Jiang; Jia Li; Lili Zhao; Shuoqi Yang; Xiaoyong Chen; Minghui Wang; Jianshi Zheng; Fangfang Wu; Ruiliang Wu; Lihong Ren; Liang Bu; Houzhao Wang; Ke Li; Lijuan Fu; Guojun Zhang; Yali Zheng; Zhancheng Gao
Journal:  Research (Wash D C)       Date:  2022-06-16

3.  mRNA vaccination in people over 80 years of age induces strong humoral immune responses against SARS-CoV-2 with cross neutralization of P.1 Brazilian variant.

Authors:  Helen Parry; Gokhan Tut; Rachel Bruton; Sian Faustini; Christine Stephens; Philip Saunders; Christopher Bentley; Katherine Hilyard; Kevin Brown; Gayatri Amirthalingam; Sue Charlton; Stephanie Leung; Emily Chiplin; Naomi S Coombes; Kevin R Bewley; Elizabeth J Penn; Cathy Rowe; Ashley Otter; Rosie Watts; Silvia D'Arcangelo; Bassam Hallis; Andrew Makin; Alex Richter; Jianmin Zuo; Paul Moss
Journal:  Elife       Date:  2021-09-29       Impact factor: 8.140
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.